Treatment for systemic sclerosis-associated interstitial lung disease
Treatment for systemic sclerosis-associated interstitial lun... : Current Opinion in
Rheumatology Treatment for systemic sclerosis-associated interstitial lung disease : Current …
Rheumatology Treatment for systemic sclerosis-associated interstitial lung disease : Current …
Esophageal dysfunction in systemic sclerosis: an update
B Li, J Yan, J Pu, J Tang, S Xu, X Wang - Rheumatology and Therapy, 2021 - Springer
Esophageal motility disorders are prevalent in 90% of patients with systemic sclerosis
[scleroderma (SSc)], with an increased mortality rate in patients with severe esophageal …
[scleroderma (SSc)], with an increased mortality rate in patients with severe esophageal …
Tofacitinib in the treatment of skin and musculoskeletal involvement in patients with systemic sclerosis, evaluated by ultrasound
RV Karalilova, ZA Batalov, TL Sapundzhieva… - Rheumatology …, 2021 - Springer
Systemic sclerosis (SSc) is a rare autoimmune connective tissue disease characterized by
fibrosis of the skin and internal organs, autoimmunity-driven damage and vasculopathy. The …
fibrosis of the skin and internal organs, autoimmunity-driven damage and vasculopathy. The …
B cells in systemic sclerosis: from pathophysiology to treatment
K Melissaropoulos, D Daoussis - Clinical Rheumatology, 2021 - Springer
Systemic sclerosis is a debilitating autoimmune disease with unknown pathogenesis. The
clinical phenotype of fibrosis is preceded by vascular and immunologic aberrations …
clinical phenotype of fibrosis is preceded by vascular and immunologic aberrations …
Plasma metabolomic profiling reveals four possibly disrupted mechanisms in systemic sclerosis
T Bögl, F Mlynek, M Himmelsbach, N Sepp… - Biomedicines, 2022 - mdpi.com
Systemic sclerosis (SSc) is a rare systemic autoimmune disorder marked by high morbidity
and increased risk of mortality. Our study aimed to analyze metabolomic profiles of plasma …
and increased risk of mortality. Our study aimed to analyze metabolomic profiles of plasma …
Interstitial lung disease in patients with systemic sclerosis: toward personalized-medicine-based prediction and drug screening models of systemic sclerosis-related …
P Khedoe, E Marges, P Hiemstra, M Ninaber… - Frontiers in …, 2020 - frontiersin.org
Systemic sclerosis (SSc) is an autoimmune connective tissue disease, characterized by
immune dysregulation and progressive fibrosis. Interstitial lung disease (ILD) is the most …
immune dysregulation and progressive fibrosis. Interstitial lung disease (ILD) is the most …
Tocilizumab therapy in juvenile systemic sclerosis: a retrospective single centre pilot study
To evaluate the efficacy and safety of anti-interleukin (IL)-6 receptor antibody tocilizumab
(TCZ) as a treatment option of juvenile systemic sclerosis (JSS). Nine JSS patients were …
(TCZ) as a treatment option of juvenile systemic sclerosis (JSS). Nine JSS patients were …
Uncovering the link between inflammatory rheumatic diseases and male reproductive health: a perspective on male infertility and sexual dysfunction
M Yessirkepov, BF Kocyigit, K Zhakipbekov… - Rheumatology …, 2024 - Springer
Inflammatory rheumatic diseases (IRDs) refer to a range of persistent disorders that have a
major influence on several physiological systems. Although there is much evidence …
major influence on several physiological systems. Although there is much evidence …
Immunosuppressive and immunomodulator therapy for rare or uncommon skin disorders in pandemic days
AS Karadag, M Aslan Kayıran, T Lotti… - Dermatologic …, 2020 - Wiley Online Library
Immunosuppressive and immunomodulatory therapies are important in dermatology, but
indications are influenced by SARS‐CoV‐2. We will focus on skin disorders such as …
indications are influenced by SARS‐CoV‐2. We will focus on skin disorders such as …
Physicians Perception of Rheumatology Practice and Training in India.
Objective: To assess physicians' perception and their felt competence in dealing with
patients with rheumatic complaints. Methods: We assessed the quantum of rheumatological …
patients with rheumatic complaints. Methods: We assessed the quantum of rheumatological …